ALLR
Allarity Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$24.66M
P/E Ratio
—
EPS
$-0.70
Beta
0.38
52W High
$2.06
52W Low
$0.77
50-Day MA
$1.44
200-Day MA
$1.30
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Allarity Therapeutics Inc
Allarity Therapeutics A / S develops various therapeutic candidates for the treatment of cancer using complementary drug-specific diagnostics (cDx) generated by its drug response prediction technology. The company is headquartered in Horsholm, Denmark.
Fundamentals
| Revenue (TTM) | 320,000 |
| Gross Profit (TTM) | 320,000 |
| EBITDA | $-12.60M |
| Operating Margin | -912.00% |
| Return on Equity | -103.80% |
| Return on Assets | -38.50% |
| Revenue/Share (TTM) | $0.02 |
| Book Value | $0.52 |
| Price-to-Book | 3.53 |
| Price-to-Sales (TTM) | 77.07 |
| EV/Revenue | 75.67 |
| EV/EBITDA | -0.08 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $15.91M |
| Float | $15.74M |
| % Insiders | 4.85% |
| % Institutions | 6.15% |
Historical Volatility
HV 10-Day
89.03%
HV 20-Day
95.01%
HV 30-Day
95.66%
HV 60-Day
79.97%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($10.25 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026